Literature DB >> 22096010

Necrotizing fasciitis in a rheumatoid arthritis patient treated with tocilizumab.

Marleen G H van de Sande, Eline R van Slobbe-Bijlsma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22096010     DOI: 10.1093/rheumatology/ker336

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  6 in total

1.  IL-1β is an innate immune sensor of microbial proteolysis.

Authors:  Christopher N LaRock; Jordan Todd; Doris L LaRock; Joshua Olson; Anthony J O'Donoghue; Avril A B Robertson; Matthew A Cooper; Hal M Hoffman; Victor Nizet
Journal:  Sci Immunol       Date:  2016-08-19

2.  Three cases of severely disseminated Staphylococcus aureus infection in patients treated with tocilizumab.

Authors:  Mai T T Nguyen; Jan Pødenphant; Pernille Ravn
Journal:  BMJ Case Rep       Date:  2013-01-02

3.  Opportunistic Invasive Infection by Group A Streptococcus During Anti-Interleukin-6 Immunotherapy.

Authors:  Shyra Wilde; Katherine L Olivares; Victor Nizet; Hal M Hoffman; Suhas Radhakrishna; Christopher N LaRock
Journal:  J Infect Dis       Date:  2021-04-08       Impact factor: 5.226

4.  Tocilizumab induced acquired factor XIII deficiency in patients with rheumatoid arthritis.

Authors:  Sho Mokuda; Yosuke Murata; Naoya Sawada; Kenichiro Matoba; Akihiro Yamada; Makoto Onishi; Yasuaki Okuda; Kazuo Jouyama; Eiji Sugiyama; Kiyoshi Takasugi
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

5.  The Effect of Tocilizumab on Inflammatory Markers in Patients Hospitalized with Serious Infections. Case Series and Review of Literature.

Authors:  Mark Berman; Ronen Ben-Ami; Shlomo Berliner; Marina Anouk; Ilana Kaufman; Adi Broyde; Sara Borok; Ori Elkayam
Journal:  Life (Basel)       Date:  2021-03-20

6.  Necrotizing Soft Tissue Infections in Intensive Care.

Authors:  Alexandru Ogica; Christoph Burdelski; Holger Rohde; Stefan Kluge; Geraldine de Heer
Journal:  J Intensive Care Med       Date:  2021-04-26       Impact factor: 3.510

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.